GLP1R and type 2 diabetes mellitus: The literature lacks adequately powered, randomised, placebo-controlled intervention studies using GLP-1 analogues in patients with NAFLD, with or without T2DM, to demonstrate the inter-relationship between the biochemical, metabolic and histological responses.